Showing results (421-430 of 733) with videos related to

Sort By:
Pageof 74
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2020
Immune Checkpoint Inhibitors for Cancer Therapy in the COVID-19 EraMichele Maio, Omid Hamid, James Larkin, et al.
Clinical Genitourinary Cancer|August 6, 2024
Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study ResultsPaul Nathan, Balaji Venugopal, Jamshed Ali, et al.
Melanoma Research|February 24, 2021
The efficacy of immunotherapy for in-transit metastases of melanoma: an analysis of randomized controlled trialsRoger Olofsson Bagge, Lars Ny, Paolo A Ascierto, et al.
Plos Computational Biology|November 11, 2024
A modular protein language modelling approach to immunogenicity predictionHugh O'Brien, Max Salm, Laura T Morton, et al.
The Oncologist|May 13, 2017
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of EncephalitisJames Larkin, Bartosz Chmielowski, Christopher D Lao, et al.
British Journal of Cancer|October 7, 2020
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinomaChung-Han Lee, Robert J Motzer, Hilary Glen, et al.
Future Oncology (London, England)|July 30, 2020
Bempegaldesleukin plus nivolumab in untreated, unresectable or metastatic melanoma: Phase III PIVOT IO 001 study designNikhil I Khushalani, Adi Diab, Paolo A Ascierto, et al.
The British Journal of Dermatology|August 17, 2022
Checkpoint inhibitor-associated bullous cutaneous immune-related adverse events: a multicentre observational studyAnusuya Kawsar, Charlotte Edwards, Pooja Patel, et al.
Nature Reviews. Clinical Oncology|February 23, 2026
Innovative approaches for lung cancer screening and interceptionJianjun Zhang, Matthew D Park, Tej Pandya, et al.
European Journal of Cancer (Oxford, England : 1990)|October 23, 2018
Anti-PD-1/PD-L1 immunotherapy in patients with solid organ transplant, HIV or hepatitis B/C infectionMartin Tio, Rajat Rai, Ogochukwu M Ezeoke, et al.
Pageof 74